Healthcare

Critical guidance on your journey

With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.

Contact advisor

Worldwide

472

deals closed in Healthcare

Worldwide

Explore all our industry-related deals

Go to deals

Saneca Pharmaceuticals, a.s. has acquired Suir Pharma Ireland

Healthcare | Private Equity

Saneca Pharmaceuticals, a.s. has acquired Suir Pharma Ireland

Saneca Pharmaceuticals, a.s. (Saneca) has acquired Suir Pharma Ireland from mutares AG, an industrial holding company. Financial details have not been disclosed.

Learn more

Chirana T. Injecta, a.s. has acquired Vitrex Medical A/S

Healthcare

Chirana T. Injecta, a.s. has acquired Vitrex Medical A/S

Chirana T. Injecta, a.s. has announced the acquisition of Vitrex Medical A/S, the Danish disposable medical and laboratory devices manufacturing company developing, producing and selling disposable articles, primarily for blood sample taking and analysis. Financial details have not been disclosed.

Learn more

Chirana T. Injecta, a.s. has acquired Chirmax, s.r.o.

Healthcare

Chirana T. Injecta, a.s. has acquired Chirmax, s.r.o.

Chirana T. Injecta, a.s. has acquired a 100% stake in Chirmax, s.r.o., the Czech manufacturer of surgical suture material, for an undisclosed consideration.

Learn more

“During the last 12 years, I have made move UP what it is today, a valued partner in physical fitness for health insurers and employers. Acture shares my vision of physical health. I look forward to developing the concept of total welfare management together with Acture in Germany and the rest of Europe. I want to express my heartfelt gratitude to the Oaklins team, our invaluable partner throughout this process. Their unwavering dedication and strategic guidance played a pivotal role in navigating the complexities of this deal and we sincerely appreciate their substantial operational support. We are confident and ready to embrace a prosperous future as an integral part of the Acture family.”

Jan-Frederik Kolthoff

Founder and CEO, move UP Gesellschaft für Gesundheitsmanagement mbH

Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=CZ&includes=featured_images,tags&language=en&limit=1&tags=healthcare

Belgian radioisotope producer secures US$104.1 million to expand global production

DEAL FLASH: PanTera, a Belgian radioisotope producer, has completed a US$104.1 million (€93 million) oversubscribed Series A fundraising round led by EQT Life Sciences. Oaklins’ team in Belgium acted as the sole financial advisor in this transaction.

Learn more